Skip to content
Andarix
  • Home
  • About
  • Products
    • Tozaride ®
    • Companion Diagnostics
    • Our Science
  • News & Events
  • Contact
Andarix
  • Home
  • About
  • Products
    • Tozaride ®
    • Companion Diagnostics
    • Our Science
  • News & Events
  • Contact

Archive for April 2015

Andarix Selected to Present at Orphan Drug Congress

April 21, 2015

ANDARIX Pharmaceuticals, a clinical stage company developing a targeted peptide therapy for small cell lung and other cancers announced that its Chief Executive Officer, Chris Adams, will present at the World Orphan Drug Conference in Washington, DC on April 23, 2015. Conference location and agenda information are available at the World Orphan Drug Congress. Andarix’…

Read More

Recent Posts

  • Andarix Pharmaceuticals Awarded Trademark for Tozaride by the US Patent and Trademark Office
  • Andarix Pharmaceuticals to Present at Neosynth Breast Cancer Conference
  • Andarix Pharmaceuticals to Present Lung Cancer Clinical Trial Results at the Society of Nuclear Medicine Meeting.
  • Andarix Pharmaceuticals to present at the CBI Basket and Umbrella Trials for Oncology Conference
  • Andarix Pharmaceuticals Selected to Present at the 6th JCA-AACR Special Joint Conference on Lung Cancer

Recent Comments

    Archives

    • April 2019
    • October 2018
    • July 2018
    • February 2018
    • October 2017
    • September 2017
    • October 2015
    • September 2015
    • April 2015
    • December 2014
    • September 2014
    • July 2014
    • February 2014

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Home
    • About Us
    • Products
    • News & Events
    • Contact Us